Clinical Trials Directory

Trials / Terminated

TerminatedNCT01737957

Safety and Efficacy of Low-Fluence PRP for PDR

Safety and Efficacy of Single-session, Low-fluence Panretinal Photocoagulation (PRP) for Proliferative Diabetic Retinopathy (PDR)

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Asociación para Evitar la Ceguera en México · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To determine the safety and efficacy of a single session of low-fluence panretinal photocoagulation when compared to full-fluence PRP. Hypothesis: a single-session of low-fluence PRP will be safe regarding the progression of macular edema and the presence of adverse events, and will efficiently induce regression of neovascularization.

Conditions

Interventions

TypeNameDescription
DEVICELow-fluence PRP with 532nm green LASERTo administer low-fluence PRP in a single session for PDR
DEVICEFull-Fluence PRP with 532nm LASERTo administer full-fluence PRP in two sessions for PDR

Timeline

Start date
2012-11-01
Primary completion
2013-03-01
Completion
2013-03-01
First posted
2012-11-30
Last updated
2024-05-30

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT01737957. Inclusion in this directory is not an endorsement.